Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Bungeon Nov 13, 2020 3:10pm

838 Views

Post# 31896780

L2

Number of Shares		Bid Price
29,000 shares	29,000	0.195
207,000 shares	207,000	0.190
128,000 shares	128,000	0.185
247,000 shares	247,000	0.180
142,500 shares	142,500	0.175
65,000 shares	65,000	0.170
134,500 shares	134,500	0.165
118,500 shares	118,500	0.160
43,500 shares	43,500	0.155
21,000 shares	21,000	0.150

Level two quotes - Ask
Ask Price	Number of Shares
0.200	11,500	11,500 shares
0.205	263,000	263,000 shares
0.210	264,500	264,500 shares
0.215	47,000	47,000 shares
0.220	10,000	10,000 shares
0.225	54,500	54,500 shares
0.230	45,000	45,000 shares
0.235	33,500	33,500 shares
0.240	27,000	27,000 shares
0.245	84,500	84,500 shares